Editorial: Might Astellas be the mystery bidder for Solvay's drug business?
21 July 2009
Ian Haydock
Please Login to read the full article.
21 July 2009
Ian Haydock
ian.haydock@informa.com
Much of the speculation swirling around the possible sale of Solvay's pharmaceutical business has one thing in common: that, along with Nycomed, the other serious bidder is a Japanese firm. But which one is it?
That remains unknown, but any deal would seem to make more sense for some of Japan's...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
